Stock Price Quote

ASTER DM HEALTHCARE LTD.

NSE : ASTERDMBSE : 540975ISIN CODE : INE914M01019Industry : Hospital & Healthcare ServicesHouse : Private
BSE497.95-0.2 (-0.04 %)
PREV CLOSE ( ) 498.15
OPEN PRICE ( ) 498.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 13310
TODAY'S LOW / HIGH ( )491.35 500.70
52 WK LOW / HIGH ( )312.25 558.3
NSE497.95-0.3 (-0.06 %)
PREV CLOSE( ) 498.25
OPEN PRICE ( ) 496.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 497.95 (30)
VOLUME 1416728
TODAY'S LOW / HIGH( ) 490.00 500.45
52 WK LOW / HIGH ( )311.1 558
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 18-01 2008
Management Info
Azad Moopen - Chairman Azad Moopen - Managing Director
Registered Office

Address Awfis, 2nd Floor, Renaissance Centra,27 & 27/1, Mission Road,Sampangi Rama Nagar,
Bengaluru,
Karnataka-560027

Phone 0484 6699999

Email info@asterdmhealthcare.com

Website www.asterdmhealthcare.in

Registrars Details
MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE

NEWS

23Dec Aster DM Healthcare informs about chan
Aster DM Healthcare has informed that Dr. Nalanda Jayadev has been appoi..
10Dec Aster DM Healthcare informs about cred
Pursuant to the Regulation 30 of SEBI (Listing Obligations and Disclosur..
29Nov Aster DM Healthcare informs about pres
Aster DM Healthcare has informed that the Board has approved the issuanc..
29Nov Substantial Acquisition of Shares
Scheme of Arrangement & Preferential Issue of shares Inter-alia consider..
29Nov Allotment of Equity Shares
Scheme of Arrangement & Preferential Issue of shares Inter-alia consider..

Financials

in Millions
QTR Sep 24 ANNUAL 24
Net Profit898.41569.6
Gross Profit 1198.3 2093.5
Operating Profit 1757.44091
Net Sales 6046.820365

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Dr. Lal Pathlabs (BSE)
peergroup  2842.75 (1.73%)
M.Cap ( in Cr)23875.58
Jupiter Life Line (BSE)
peergroup  1549.30 (1.37%)
M.Cap ( in Cr)10158.14
Narayana Hrudayalay (BSE)
peergroup  1327.20 (0.68%)
M.Cap ( in Cr)27120.72
Yatharth Hospital (BSE)
peergroup  431.85 (1.90%)
M.Cap ( in Cr)4173.11
Metropolis Health. (BSE)
peergroup  1848.50 (0.40%)
M.Cap ( in Cr)9475.98

Shareholding Pattern

PROMOTERS 41.88%
MUTUAL FUNDS/UTI 22.24%
NON-INSTITUTION 12.59%
FI/BANKS/INSURANCE 0.19%
GOVERNMENT 0%
FII 0%

About Aster DM Healthcare Ltd.

Aster DM Healthcare Ltd. was incorporated in the year 2008. Its today's share price is 497.95. Its current market capitalisation stands at Rs 24875.75 Cr. In the latest quarter, company has reported Gross Sales of Rs. 20365 Cr and Total Income of Rs.20855.2 Cr. The company's management includes Wayne Earl Keathley, Daniel Robert Mintz, Emmanuel David Gootam, James Mathew , Chenayappillil John George, Purana Housdurgamvijaya Deepti, Shamsudheen Bin Mohideen Mammu Haji, Thadathil Joseph Wilson, Anoop Moopen, Zeba Azad Moopen, Sunil Theckath Vasudevan, Maniedath Madhavan Nambiar, Alisha Moopen, Azad Moopen, Azad Moopen, Hemish Purushottam.

It is listed on the BSE with a BSE Code of 540975 , NSE with an NSE Symbol of ASTERDM and ISIN of INE914M01019. It's Registered office is at Awfis, 2nd Floor, Renaissance Centra,27 & 27/1, Mission Road,Sampangi Rama NagarBengaluru-560027, Karnataka. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are BSR & Associates, BSR & Associates LLP, Deloitte Haskins & Sells, Singhi & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.